1. Medicines
  2. Oncology
  3. TAFINLAR® (dabrafenib) + MEKINIST® (trametinib)
  4. Resources

Prescribing information

 

TAFINLAR (dabrafenib) + MEKINIST (trametinib) Resources

   

Please use the links below to view the electronic versions of certain TAFINLAR + MEKINIST resources.

Please contact your Novartis Representative to enquire about available electronic or hard copies.

UK | December 2020 | 100923
Oncology
Article
Product resource
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at http://www.report.novartis.com/
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]